Royal Philips is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries.

Our business segments are:
o Diagnosis & Treatment Systems, smart devices, software and services, powered by AI-enabled informatics Supporting precision diagnosis and minimally invasive treatment in a growing number of therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology
o Connected Care Ambulatory, home-based and in-hospital monitoring and workflow solutions fueled by advanced interoperability and patient data insights
Connecting patients and caregivers across care settings, delivering clinical, operational and therapeutic solutions
o Personal Health Broad range of consumer solutions to support people in proactively managing their health and well-being